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A B S T R A C T
Purpose: This exploratory study aimed to examine emotion-processing styles in patients with
psychogenic non-epileptic seizures (PNES), compared to healthy individuals, and to explore associations
of emotion processing with other psychological measures and seizure frequency, using the new
Emotional Processing Scale (EPS-25), which had not previously been used in this patient group.
Methods: Fifty consecutive patients with PNES referred for psychotherapy completed a set of self-report
questionnaires, including the Emotional Processing Scale (EPS-25), Clinical Outcome in Routine
Evaluation (CORE-10), Short Form-36 (SF-36), Patient Health Questionnaire (PHQ-15), and Brief Illness
Perception Questionnaire (BIPQ). Responses on the EPS-25 were compared to data from 224 healthy
controls.
Results: Patients with PNES had greater emotion processing deﬁcits across all dimensions of the EPS-25
than healthy individuals (suppression/unprocessed emotion/unregulated emotion/avoidance/impover-
ished emotional experience). Impaired emotion processing was highly correlated with psychological
distress, more frequent and severe somatic symptoms, and a more threatening understanding of the
symptoms. Emotion processing problems were also associated with reduced health-related quality of
life on the mental health (but not the physical health) component of the SF-36. The unregulated
emotions sub-scale of the EPS was associated with lower seizure frequency.
Conclusion: The results showed clear impairments of emotion processing in patients with PNES
compared to healthy individuals, which were associated with greater psychological distress and reduced
mental health functioning. These ﬁndings seem to support the face validity of the EPS-25 as a measure
for PNES patients and its potential as a tool to assess the effectiveness of psychological interventions.
 2015 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Psychogenic non-epileptic seizures (PNES) are episodes of
alteration of consciousness and disturbance of sensory, motor,
autonomic or cognitive functions that superﬁcially resemble
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and behavioural response to psychological distress perceived by
patients as involuntary [1]. Most fulﬁl the diagnostic criteria of
a conversion or somatic symptom disorder in the Diagnostic and
Statistical Manual of Mental Disorders (DSM-5) [2] or of
dissociative convulsions in the International Classiﬁcation of
Diseases (ICD-10) [3].
Within the current bio-psycho-social model, PNES are
explained as resulting from the interaction of multiple predispos-
ing, precipitating and perpetuating factors, including a dysfunc-
tional family environment, childhood abuse or other traumatic
experiences [1]. The association with early life adversity and
traumatic experiences means that PNES could be linked to
abnormal emotion processing [4]. Emotion processing can broadly
be deﬁned as the way in which individuals process and absorb
emotional disturbances associated with adverse life events [5,6].served.
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able ambiguity in the conceptualisation of its association to related
constructs such as emotion regulation, emotion expressiveness,
emotion intelligence, emotion control or alexithymia [7,8]. In
particular, there seems to be an overlap between the concepts
of emotion regulation, described as ‘‘the processes responsible for
the monitoring, evaluating, and modifying of emotional reactions
to accomplish one’s goals’’ [9], alexithymia or difﬁculties in
understanding and expressing emotions [10] and emotion
processing.
Baker et al. [7] developed a model of emotion processing which
integrates the different emotion-related concepts. According to
this model, emotion processing consists of an input in the form of
an event that is consciously or unconsciously registered, followed
by rapid and unconscious appraisal of the event and subsequent
emotional experience, which is central to the processing of
emotion and includes awareness of emotions, experiencing
emotions as psychological wholes, identifying and labelling of
emotions and linking them to relevant causal events. The ﬁnal
output stage is an appropriate expression of emotions. Incomplete
processing characterised by prolonged or excessive avoidance and/
or inhibition of negative emotions can result in intrusive or
obsessive thoughts, disturbances of behaviour and experience, and
further prevents the integration and resolution of negative
emotional experiences [7,11]. Abnormal emotion processing has
been associated with the development and maintenance of a
number of psychological disorders, including Posttraumatic Stress
Disorder [12], panic [6], depression [13] and psychosomatic
conditions [14], such as ﬁbromyalgia [15], chronic fatigue
syndrome [16] and chronic pain [17].
An adapted form of this model has been applied to PNES,
suggesting that PNES might actually be conceptualised as
manifestations of abnormal emotion processing [11]. A number
of experimental and self-report studies have investigated different
concepts related to emotion processing in PNES and described
abnormalities in relation to healthy controls, patients with
epilepsy or healthy controls with a history of trauma [4,18–22].
As PNES are characterised by a heterogeneous aetiology and
comorbid psychopathology, the studies have also explored the
possibility that there may be several clinically distinct subpopula-
tions of patients with PNES using cluster analysis [4,20,21]. The
results suggest that there may be at least two clusters of PNES
patients characterised by higher or lower levels of emotion
dysregulation and higher or lower levels of abnormality in terms of
psychopathology or personality proﬁles. These studies indicate
that, whilst levels of emotion dysregulation may be higher in PNES
than in the healthy population, the nature and extent of emotion
dysregulation may depend on interactions with other psychologi-
cal factors present in the disorder.
‘‘Alexithymia’’ is one particular emotion-processing problem,
which has been studied more extensively in patients with PNES: a
recent study has found a 36.9% prevalence of alexithymia in
patients with PNES. Alexithymia was associated with symptoms of
psychological trauma, including intrusive experiences and defen-
sive avoidance, and cynicism [23]. This corresponds with earlier
ﬁndings of Tojek et al. [24] who reported high alexithymia scores in
approximately 30% of patients with PNES. Bewley et al. [10] found
considerably higher levels of alexithymia in patients with PNES
(90.5%); however, levels of alexithymia in that study did not
differentiate between patients with PNES, patients with epilepsy
and healthy controls when co-morbid anxiety and depression were
accounted for.
Another speciﬁc aspect of emotion processing which has
received particular attention in patients with PNES is avoidance
(including avoidance of emotions). Several self-report and
experimental studies have revealed evidence of increased levelsof avoidance in patients with PNES and have demonstrated a
positive correlation between avoidance and PNES frequency and
a negative correlation between avoidance and health-related
quality of life (HRQoL) [25–29].
Given that PNES can be interpreted as an externalised form of
abnormal emotion processing, there is a clear need for further
research that would shed more light on emotion generation,
perception, regulation and expression processes in patients with
PNES as well as the interaction of emotion processing problems
with other psychological factors. This exploratory study therefore
aims to describe emotion processing styles of patients with PNES
compared to healthy individuals, using the new Emotional
Processing Scale (EPS-25) [30] developed on the basis of the
integrative model of emotion processing described above, encom-
passing a broader range of different emotional processing deﬁcits
than other emotion scales. As a secondary aim, this study sought
to explore the clinical utility of the EPS-25 as a measure to assess
patients with PNES in the planning stage of therapeutic interven-
tions or as a process measure before and after treatment.
2. Methods
2.1. Subjects
Patients with PNES were recruited consecutively from those
referred to the Neurology Psychotherapy Service at the Royal
Hallamshire Hospital and Barnsley Hospital for psychotherapy. All
patients had been diagnosed by experienced consultant neurol-
ogists with a specialist interest in seizure disorder based at the
Shefﬁeld Teaching Hospitals NHS Foundation Trust on the basis of
all clinical information available (including video-EEG recordings
of typical events in most cases). All patients provided written
informed consent.
Demographic and Emotional Processing Scale (EPS-25) data
from 224 healthy controls provided by the developers of the EPS
were used for comparison [30,31]. The healthy controls were
recruited from a range of community sources and workplaces.
They were matched in age and gender with the PNES group.
2.2. Design and procedure
This is a prospective, cross-sectional study. The study has been
approved by the Shefﬁeld Local Research Ethics Committee on 1st
May 2009. The study was undertaken at the Shefﬁeld Teaching
Hospitals NHS Foundation Trust Department of Neurology.
Information concerning the study was sent to patients when
they were invited in for their initial assessment session with a
psychotherapist. In the assessment session, patients were screened
for serious psychiatric conditions, suicide risk and suitability for
psychotherapy, the diagnosis of PNES was further explained, and
they were introduced to a range of self-help strategies. They were
also given another copy of the patient information form and
invited to join the study at the end of the assessment session.
Written informed consent was taken at this point. Patients who
agreed to take part were asked to complete a set of self-report
measures after this initial session but before their ﬁrst therapy
session (approximately 3 months after the initial assessment).
2.3. Measures
2.3.1. Demographic and referral questionnaires
Demographic and clinical information was collected on
questionnaires completed by patients and the referring neurol-
ogists. The frequency of PNES was calculated as the number of
attacks per month. In addition, given the non-normal distribution
of the data, seizure frequency was further examined by
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seizure per year but less than one seizure per month, (2) more than
one seizure per month but less than one seizure per week, (3)
more than one seizure per week but less than one seizure per day,
(4) more than one seizure per day but less than one seizure per
hour, (5) more than one seizure per hour.
2.3.2. Clinical Outcome in Routine Evaluation (CORE-10)
The CORE-10 is a brief self-report questionnaire measuring
global psychological distress, using ten items drawn from the
34-item CORE-OM (outcome measure) [32]. Each item is scored on
a ﬁve-point scale ranging from 0 to 4 with higher scores indicating
a greater level of distress. The CORE-OM has been validated in
large clinical and non-clinical samples and correlates closely with
different measures of psychological distress, including Beck
Depression Inventory [33] and Beck Anxiety Inventory [34].
Response values of the ten items were added to produce a total
clinical score (a = .915). For subjects with one item missing, the
total score was computed as a mean of the completed items
multiplied by the number of all items, as suggested by the user
manual. Subjects with more than one item missing were excluded
from the analyses (N = 2).
2.3.3. Short Form-36 (SF-36)
The SF-36 is a 36-item self-report questionnaire providing one
multi-item scale measure of eight areas of HRQoL: physical
functioning, role limitation – physical, bodily pain, general health,
vitality, social functioning, role limitation – emotional, and mental
health. Items are scored on scales offering two to six answers.
Missing data were replaced by the mean of the completed data
in the sub-scale, as recommended by the user manual [35].
Subjects with more than a half of the items on any sub-scale
missing were excluded from the analyses (N = 1). The scores on the
eight sub-scales were re-coded, standardised using norm-based
scoring and combined into physical (PHS, a = .797) and mental
(MHS, a = .780) health scales, following a previously described
procedure [35,36].
2.3.4. Patient Health Questionnaire (PHQ-15)
The PHQ-15 comprises 15 physical symptoms, extracted from
the Patient Health Questionnaire, which forms part of the self-
administered PRIME-ED diagnostic instrument for common
mental disorders [37]. Symptoms over the last 4 weeks are rated
on a three-point scale as 0 (‘not bothered at all’), 1 (‘bothered a
little’) or 2 (‘bothered a lot’) [38].
A total score is calculated as a sum of scores on the 15 items of
the PHQ-15. There was a considerable number of missing data on
item 4 in our sample (N missing = 11), addressing menstrual
problems and item 11 (N missing = 6), addressing problems with
sexual intercourse. As these questions may not have been
applicable to a proportion of participants, the items were excluded.
For the remaining 13 items, two or fewer missing data per subject
were replaced by median scores (resulting total score a = .849).
2.3.5. Brief Illness Perception Questionnaire (BIPQ)
The BIPQ is a nine-item scale designed to assess the cognitive
and emotional representations of illness. The nine items represent
dimensions of illness perceptions including consequences, time-
line, personal control, treatment control, identity, illness concern,
coherence, emotional representation and perceived causes [39]. All
items apart from item 9, which is an open-ended question, are
scored on an eleven-point scale, ranging from 0 to 10.
The relevant items of the scale were reverse-coded and the
eight items were added to produce total score representing the
degree to which the condition is perceived as threatening
(a = .732). For subjects with one item missing, the total scorewas computed as a mean of the completed items multiplied by the
number of all items, as recommended by the scoring instructions.
Subjects with more than one item missing were excluded from the
analyses (N = 3).
2.3.6. Emotional Processing Scale (EPS-25)
The 25-item EPS is a self-administered questionnaire developed
to identify and quantify different emotional processing styles and
deﬁcits [30,31]. The scale has been derived from the 38-item EPS
[7]. The EPS-25 contains ﬁve subscales: suppression, signs of
unprocessed emotion, unregulated emotion, avoidance and
impoverished emotional experience and it has been shown to
have satisfactory reliability, test-retest reliability and to correlate
well with the Toronto Alexithymia Scale (TAS-20) and the
Courtauld Emotional Control Scale [7].
Responses of the PNES group to individual questions were
combined into the ﬁve sub-scales and assessed for internal
consistency reliability. The reliability of the subscales was
acceptable to excellent (suppression a = .940, unprocessed emo-
tion a = .926, unregulated emotion a = .746, avoidance a = .772
and impoverished emotional experience a = .865). The ﬁve sub-
scales were combined into a total score (a = .921). Missing data on
one item was replaced by the mean of the completed data in the
sub-scale, as recommended in the Administrator’s manual of
the EPS [7,31]. Subjects with more than one item missing were
excluded from the analysis (N = 1).
2.4. Statistical analyses
Data were analysed using SPSS (version 19; SPSS Inc., Chicago,
IL, USA). The Shapiro–Wilk test was carried out to assess the
normality of the distribution of the data. The distributions of
the scores on PHQ-15, MHC and PHS scale of the SF-36 as well as
the compound EPS were found not to be normal. In view of this,
non-parametric Spearman’s correlational analyses were per-
formed to examine possible relationships between emotional
processing and the other self-report measures in the PNES group.
To consider differences in emotional processing between the PNES
patient group and healthy controls, Mann–Whitney U-tests were
performed.
In view of the fact that this is an exploratory study, no
adjustments were made for multiple comparisons. Two-sided
p-values of <0.05 were considered statistically signiﬁcant.
3. Results
3.1. Subjects
Of 55 patients with PNES recruited to this study, 50 (14% male)
returned a complete set of questionnaires and were included in the
analyses. Their responses on the EPS were compared to those from
224 (13.8% male) healthy controls. Subjects in the PNES group
ranged in age from 17 to 74 years (median = 39, interquartile
range = 24.00). The group of healthy controls ranged from 17 to 78
years (median = 32, interquartile range = 22.00). There was no
signiﬁcant difference in age or gender distribution between the
two groups (p > .05).
3.2. Comparison of the PNES and healthy control groups
Comparisons of the measure of emotional processing (EPS)
were made between patients with PNES (N = 49) and the healthy
control group (N = 224).
The Mann–Whitney U-test showed that the total EPS scores as
well as all of the scores on the EPS sub-scales were signiﬁcantly
higher in the PNES group than in the healthy control group (Fig. 1).
Fig. 1. Signiﬁcant differences between the PNES and healthy control group in the
median values of the total EPS scores and scores on the ﬁve EPS sub-scales (*
differences are signiﬁcant at p < 0.001).
Table 1
Correlation matrix of the EPS sub-scales in PNES.
1 2 3 4 5 6
1. Suppression
2. Unprocessed emotion .627*
3. Unregulated emotion .424* .733*
4. Avoidance .588* .709* .681*
5. Impoverished emotional experience .693* .661* .562* .638*
6. Total EPS .789* .853* .779* .819* .848*
* Correlation is signiﬁcant at the 0.01 level.
Table 3
Median values and interquartile ranges of the outcome measures including somatic
symptom severity (PHQ-15), health-related quality of life (SF-36), psychological
distress (CORE-10), illness perceptions (BIPQ) and seizure frequency in the PNES
group.
Outcome measure N M IQR
PHQ-15 50 13.00 11.25
SF-36
Physical Health Scale 49 31.98 15.99
Mental Health Scale 49 30.28 16.75
CORE-10 48 20.50 14.50
BIPQ 47 52.00 17.00
Seizure frequency (attacks/month) 45 8.00 27.25
N = number of subjects; M = median; IQR = interquartile range. Variation in sample
sizes indicates missing data for certain variables.
Table 4
Correlation matrix showing the correlations between the compound EPS score and
the other scales, including the PHQ-15, CORE-10, BIPQ, and the MHS and PHS
summary sub-scales of the SF-36.




BIPQ .475* .582* .723*
SF-36 MHS .702* .478* .809* .697*
SF-36 PHS 0.088 .476* 0.085 .442* 0.031
* Correlation is signiﬁcant at the 0.01 level.
B. Novakova et al. / Seizure 29 (2015) 4–10 73.3. Correlational analyses within the PNES group
Examination of the associations between the individual EPS
subscales using Spearman’s correlation showed signiﬁcant positive
moderate to high relationships between all of the EPS sub-scales
(Table 1).
The relationships between seizure frequency and the EPS scores
are detailed in Table 2. Only one subject fell in the categories ‘more
than one seizure per year but less than one seizure per month’ and
‘more than one seizure per hour’. These two extreme cases were
excluded as outliers.
The differences in EPS scores between the remaining three
seizure frequency categories were assessed using Kruskal–Wallis
test. The only signiﬁcant difference was found in the unregulated
emotion sub-scale (X2 = 6.04, p = .049).Table 2
Median EPS scores in the different seizure frequency categories.
Seizure category 
More than 1 seizure/month but






Suppression 7.2 (3.00) 5
Unprocessed emotion 6.4 (2.20) 5
Unregulated emotion 5.60 (2.60) 4
Avoidance 6.40 (3.40) 4
Impoverished emotional experience 5.00 (3.00) 3
Total EPS 6.12 (2.16) 4
M = median; IQR = interquartile range.Table 3 provides information about the scores of the 50 patients
in the PNES group on the other self-report measures used in this
study.
Given that all of the EPS sub-scales were signiﬁcantly correlated
with each other and with the total score, the associations of the EPS
with the other self-report measures are only reported for the
compound EPS score. Spearman’s correlation showed a signiﬁcant
positive relationship between the compound EPS score (higher
scores signify more dysfunctional emotion processing) and
somatic symptoms as measured by the PHQ-15. The EPS was also
correlated positively with psychological distress as measured by
the CORE-10, and overall illness perceptions as measured by the
BIPQ (reﬂecting a more threatening view of the illness).
There was a strongly negative correlation between the EPS and
the Mental Health Scale but not the Physical Health Scale of the
health-related quality of life measure (SF-36) (lower values on the
SF-36 sub-scales indicate lower quality of life). For correlation
coefﬁcients see Table 4.
The patients with the lowest EPS scores in this study reported
very low psychological distress, demonstrating their lack of insight
into the aetiology of their seizures. All the patients were
subsequently seen for psychotherapy by one of the authors (SH)
who experienced most of this group as emotionally ‘ﬂat’ andp-Values
re than 1 seizure/week but
s than 1 seizure/day
(IQR)
More than 1 seizure/day but
less than 1 seizure/hour
M (IQR)
 12
.80 (6.60) 7.30 (2.70) n.s.
.00 (6.80) 6.70 (2.35) n.s.
.40 (5.00) 3.80 (1.45) .049
.80 (3.40) 6.20 (2.25) n.s.
.80 (5.40) 5.20 (3.40) n.s.
.32 (5.70) 6.20 (1.91) n.s.
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istrator’s Manual of the EPS [31] highlights that whilst high scores
clearly indicate emotional processing deﬁcits, signiﬁcantly low
scores should not imply healthy functioning, but may represent a
poor understanding of one’s emotional life. Whilst there was no
obvious single factor uniting this group, three of the ten lowest
scorers were wheelchair-bound and seemed to have settled into a
life of disability and dependence. Three of the group had suffered
from frequent accidents affecting their mobility and periods of
hospitalisation as children, which resulted in them receiving extra
attention from their parents. In two of these cases PNES started
immediately after their mobility had been restored. This may be an
area that warrants further study.
4. Discussion
This study was intended to increase our understanding of
emotion processing in PNES patients using the EPS-25, a ﬁve-factor
measure, which has been validated in patients with a range of
physical health problems, mental health problems, including PTSD
[40], and patients suffering from pain, including ﬁbromyalgia,
rheumatoid arthritis and chronic lower back pain [30] but has not
previously been used in patients with PNES. This study showed
that, compared to healthy individuals, people with PNES have
greater deﬁcits in all ﬁve dimensions of emotional processing
described by the EPS-25. In terms of the broad range of emotional
processing disturbances, the patients with PNES in our study are
similar to patients with Posttraumatic Stress Disorder (PTSD)
previously studied with the same measure [40], as well as a
group of patients with a range of mental health problems referred
by general medical practitioners to a counsellor or a clinical
psychologist [30]. In contrast, in a study in which patients suffering
from pain (ﬁbromyalgia, rheumatoid arthritis and chronic lower
back pain) were compared to healthy controls the patients
exhibited signiﬁcant deﬁcits only in the avoidance and impover-
ished emotional experience domains, and therefore showed much
more limited emotional processing problems than the group of
patients with PNES described here [30].
Furthermore, the mean overall score as well as the mean scores
on the ﬁve EPS-25 sub-scales of patients with PNES in our study
appear higher than those of the mental health and pain
(ﬁbromyalgia, rheumatoid arthritis and chronic lower back pain)
groups mentioned above [30]. Although we are unable to make
direct statistical comparisons with these previously described
patient groups this suggests that, compared to other patient
groups, patients with PNES have particular difﬁculties with
emotion processing and regulation.
The disease groups studied using the EPS-25 seem to be
characterised by different patterns of emotional processing
deﬁcits: the highest scores in the mental health problems [30]
and PTSD [40] groups mentioned above were seen in the
unprocessed emotions dimension (a sub-scale suggesting pro-
blems with emotions that are felt to be overwhelming or intrusive).
Patients in the previously mentioned pain group [30] scored
highest on the avoidance sub-scale whereas the patients with PNES
described here showed the greatest deﬁcits in the suppression
domain of the EPS.
Our ﬁndings indicate that, similarly to patients suffering from
other psychosomatic conditions such as pain, patients with PNES
have a strong tendency to suppress emotions and avoid situations
that may evoke them. However, despite their best efforts, they
experience emotions as overwhelming and uncontrollable at
times. This suggests that it may be the fear of intolerable emotions
that underlies the tendency to avoid experiencing and processing
them, and conversely, that emotions that are not faced, recognised
and processed may build up until they are uncontrollable. This is inkeeping with the abnormal patterns of emotional experience and
expression found by Roberts et al. as well as with the clinical
experience of practitioners offering psychological treatment of
PNES and previous studies demonstrating the importance of
avoidance in this patient group [22,25–28].
Impaired emotion processing was highly correlated with
greater levels of psychological distress measured by the CORE-
10. This could reﬂect a reciprocally causative and reinforcing
relationship between the two, whereby people experiencing high
levels of emotional distress are more likely to have a tendency to
avoid painful emotions, but therefore never develop the ability to
alleviate the distress by processing their feelings.
The examination of the relationship between the EPS and the
PHQ-15 showed that the impaired emotion processing in the PNES
group was also associated with more severe somatic symptoms. In
superﬁcial contrast with this ﬁnding, deﬁcits in emotion proces-
sing were associated with reduced HRQoL as measured by the
mental health component but not the physical health component
of the SF-36, i.e. subjects felt it was emotional rather than physical
factors that impinged on their quality of life. This ﬁnding is in
keeping with previous studies showing an association between
emotional avoidance and reduced HRQoL [29].
The discrepancy between the correlation of impaired emotion
processing with somatic symptoms and the lack of correlation with
physical functioning could stem from the different types of
physical difﬁculties that these two scales capture. Whilst the PHQ-
15 assesses more stress-related or autonomic symptoms such as
pounding heart, tiredness, dizziness or pain that may be highly
relevant to the experience of PNES, the physical functioning
measured by the SF-36 is more focussed on mobility and physical
activities such as walking, bending or bathing, which may not be
the main source of disability in PNES patients. Patients with PNES
may be more affected by subjective physical symptoms and by the
emotional issues relating to their seizures than the absolute
limitations of physical functioning they may cause.
Although emotion-processing problems were associated with a
more threatening and pessimistic understanding of the symptoms
as measured by the BIPQ, self-reported emotion processing deﬁcits
were not related to greater seizure frequency. Conversely, the
unregulated emotions sub-scale of the EPS was associated with
lower frequency of PNES. Unregulated emotions refers to the
presence of powerful emotional feelings ‘e.g. I felt the urge to
smash something’ and how much control is felt over the feelings.
e.g. ‘I reacted too much to what people said or did’. It is connected
to problems in emotional expression. Those with the lowest
frequency of seizures have a poorer (higher) EPS score, i.e. they
have more powerful feelings, which they do not feel in control of.
Conversely those with most seizures feel more control. This may
suggest seizures operate as a method of dealing with powerful
emotions and give the person a sense of greater control. This
ﬁnding resonates with the results of a study by Dimaro et al. [25],
which compared explicit and implicit anxiety and self-esteem in
patients with PNES, those with epilepsy and healthy controls.
Dimaro et al. found discrepancies between explicit and implicit
anxiety and self-esteem measures in the PNES but not the other
two participant groups. They interpreted their ﬁndings as
indicating that PNES may serve a protective function: whilst
patients with PNES (explicitly) self-reported high levels of anxiety
and low levels self-esteem, the Implicit Relational Assessment
Procedure (IRAP) measures suggested that their self-image was not
characterised by elevated anxiety or reduced self-esteem [25,41].
4.1. Limitations
The cross-sectional design of this study means that it is not
possible to draw any conclusive inferences about causality from
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to explore the associations further and to assess the sensitivity of
this measure to change in this patient group.
There are limitations associated with the use of self-report
measures, which can only measure explicitly recognised experi-
ences rather than unconscious implicit experiences, which are not
accessible to self-report. Discrepancies between explicit and
implicit emotion awareness may well be particularly relevant in
this patient group experiencing extreme abnormalities of emo-
tional processing [11,25].
PNES are a very heterogeneous disorder and it is possible that
some of our unexpected ﬁndings are accounted for by a subgroup
of PNES patients in this study who scored very low on the EPS. Low
scores could be consistent with very good emotional adjustment
but may reﬂect extreme limitations of self-reﬂective insight or
reporting bias associated with particularly marked emotion
processing problems. Ideally future studies using self-report
measures should include the prospective collection of additional
data (for instance physiological or implicit measures) to gain a
better understanding of this issue.
It would also be of interest, in future studies, to compare
emotion processing deﬁcits in patients with PNES with those seen
in patients with epilepsy, i.e. a pathogenetically different seizure
disorder. Ideally such a study would subdifferentiate between
patients with different types of epilepsy and include additional
measures to exploring the aetiology of emotion processing deﬁcits
(which is likely to be different in PNES and epilepsy).
5. Conclusion
In conclusion, this study shows clear differences in emotion
processing as represented by the EPS scores between patients with
PNES and healthy controls. Impaired emotion processing in
patients with PNES correlates highly with emotional distress, a
negative view of their illness, and a greater number and severity of
physical symptoms in addition to their seizures. Whilst emotion-
processing deﬁcits were strongly associated with reduced mental
health functioning, there was no correlation between the overall
degree of self-reported emotion processing abnormalities and
PNES frequency or physical functional impairment. The ﬁndings
suggest that in most cases it is the over-control rather than lack of
control of emotions that is associated with physical symptom-
atology.
Whilst there are clear differences in EPS scores between
patients with PNES and healthy controls and whilst the positive
correlations with measures of distress and the negative correla-
tions with the mental health component of the HRQoL measure
used in this study support the face validity of the EPS as a
measure in this patient group, this cross-sectional study cannot
determine whether the EPS provides much additional informa-
tion about patients with PNES. However, given that all recently
described psychotherapies for PNES speciﬁcally target emotion
processing as an area for improvement [42], the EPS could
provide a useful tool for assessing the effectiveness of psycho-
logical intervention.
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